Clarus R and D Solutions Revenue and Competitors
Estimated Revenue & Valuation
- Clarus R and D Solutions's estimated annual revenue is currently $1.4M per year.
- Clarus R and D Solutions's estimated revenue per employee is $87,000
Employee Data
- Clarus R and D Solutions has 16 Employees.
Clarus R and D Solutions's People
Name | Title | Email/Phone |
---|---|---|
1 | Divisional VP, Software Engineering | Reveal Email/Phone |
2 | Executive Director, Sales | Reveal Email/Phone |
3 | CEO | Reveal Email/Phone |
4 | CTO | Reveal Email/Phone |
5 | VP Operations | Reveal Email/Phone |
6 | Director Software Engineering | Reveal Email/Phone |
7 | Director Customer Success | Reveal Email/Phone |
8 | Director, Financial Planning & Analysis (Clarus R+D, a TriNet company) | Reveal Email/Phone |
9 | Director People | Reveal Email/Phone |
10 | Director Partnerships | Reveal Email/Phone |
Clarus R and D Solutions Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5554.8M | 19642 | N/A | N/A | N/A |
#2 | $371.6M | 1999 | -2% | $868M | $3.5B |
#3 | $2570M | 52 | 0% | N/A | $3.9B |
#4 | $77.2M | 426 | N/A | N/A | N/A |
#5 | $123.6M | 1358 | N/A | N/A | N/A |
#6 | $0.3M | 4 | N/A | N/A | N/A |
#7 | $8M | 110 | 9% | N/A | N/A |
#8 | $0.9M | 10 | N/A | N/A | N/A |
#9 | $19.6M | 135 | N/A | N/A | N/A |
#10 | $0.2M | 3 | N/A | N/A | N/A |
#11 | $0.2M | 6 | N/A | N/A | N/A |
#12 | $12.7M | 67 | N/A | N/A | N/A |
#13 | $5M | 43 | N/A | N/A | N/A |
#14 | $0.5M | 5 | N/A | N/A | N/A |
#15 | $5.3M | 46 | N/A | N/A | N/A |
#16 | $1.5M | 17 | N/A | N/A | N/A |
#17 | $24.6M | 91 | N/A | N/A | N/A |
#18 | $65.6M | 362 | N/A | N/A | N/A |
#19 | $1.9M | 19 | N/A | N/A | N/A |
#20 | $76.6M | 258 | 5% | N/A | N/A |
What Is Clarus R and D Solutions?
N/A
Total Funding
16
Number of Employees
$1.4M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Clarus R and D Solutions News
2022-04-19 - Clarus Therapeutics Announces Closing of Upsized $30.0 ...
(Clarus) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic...
2022-04-19 - Clarus Therapeutics Announces Notice of Allowance for Patent Claims
Covering JATENZO® (testosterone undecanoate)
(Clarus) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic...
2022-04-06 - St. Louis-based Clarus Communications expands with merger ...
As part of the deal, Connectivity Source will merge into Clarus Communications and take on the St. Louis firm's name. Financial terms of the...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7.5M | 16 | -16% | N/A |
#2 | $4M | 16 | -11% | N/A |
#3 | $2.4M | 16 | 0% | N/A |
#4 | $2.1M | 16 | -38% | N/A |
#5 | N/A | 16 | 7% | N/A |